The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world’s first and only medical device that can monitor and respond to brain activity.
NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company’s initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.
In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.
NeuroPace total Funding
NeuroPace latest funding size
Time since last funding
|9 months ago|
|InterWest Partners, KCK, Kleiner Perkins Caufield & Byers, OrbiMed, New Enterprise Associates, Johnson & Johnson Development Corporation, MedVenture Associates|
NeuroPace has 523 number of Twitter Followers. The number of followers has grown 0.3% month over month and grown 4.5% quarter over quarter
NeuroPace has 12.31k number of Facebook Likes. The number of likes has grown 4.7% month over month and grown 15.4% quarter over quarter